These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 17206391)

  • 1. Percutaneous placement of peritoneal port-catheter in patients with malignant ascites.
    Ozkan O; Akinci D; Gocmen R; Cil B; Ozmen M; Akhan O
    Cardiovasc Intervent Radiol; 2007; 30(2):232-6. PubMed ID: 17206391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologically placed tunneled peritoneal catheter in palliation of malignant ascites.
    Akinci D; Erol B; Ciftci TT; Akhan O
    Eur J Radiol; 2011 Nov; 80(2):265-8. PubMed ID: 20692116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It's not just for laparoscopy anymore: use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intraperitoneal chemotherapy catheters.
    Henretta MS; Anderson CL; Angle JF; Duska LR
    Gynecol Oncol; 2011 Nov; 123(2):342-5. PubMed ID: 21840583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term semi-permanent catheter use for the palliation of malignant ascites.
    Brooks RA; Herzog TJ
    Gynecol Oncol; 2006 May; 101(2):360-2. PubMed ID: 16499957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites.
    O'Neill MJ; Weissleder R; Gervais DA; Hahn PF; Mueller PR
    AJR Am J Roentgenol; 2001 Sep; 177(3):615-8. PubMed ID: 11517056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of Palliative Tunneled Peritoneal Drainage Catheters in the Management of Refractory Malignant and Non-malignant Ascites.
    Knight JA; Thompson SM; Fleming CJ; Bendel EC; Neisen MJ; Neidert NB; Stockland AH; Bjarnason H; Woodrum DA
    Cardiovasc Intervent Radiol; 2018 May; 41(5):753-761. PubMed ID: 29344716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal ports for treatment of intractable ascites.
    Savin MA; Kirsch MJ; Romano WJ; Wang SK; Arpasi PJ; Mazon CD
    J Vasc Interv Radiol; 2005 Mar; 16(3):363-8. PubMed ID: 15758132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indwelling catheters for the management of malignant ascites.
    Lee A; Lau TN; Yeong KY
    Support Care Cancer; 2000 Nov; 8(6):493-9. PubMed ID: 11094995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
    Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
    Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
    Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a pleural implantable access system for the management of malignant pleural effusion: the Institut Curie experience.
    Daniel C; Kriegel I; Di Maria S; Patrubani G; Levesque R; Livartowski A; Esteve M
    Ann Thorac Surg; 2007 Oct; 84(4):1367-70. PubMed ID: 17889000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter].
    Semmo N; Seuthe B; Thimme R; Graf KJ
    Dtsch Med Wochenschr; 2009 Oct; 134(41):2073-6. PubMed ID: 19802769
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of indwelling tunneled PleurX® catheter placement in pediatric and young adult patients with malignant effusions.
    Adams J; Auger J; Schiff D
    Pediatr Blood Cancer; 2014 Jun; 61(6):1118-20. PubMed ID: 24474328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleurx tunneled catheter in the management of malignant ascites.
    Richard HM; Coldwell DM; Boyd-Kranis RL; Murthy R; Van Echo DA
    J Vasc Interv Radiol; 2001 Mar; 12(3):373-5. PubMed ID: 11287517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of percutaneous management techniques for recurrent malignant ascites.
    Rosenberg S; Courtney A; Nemcek AA; Omary RA
    J Vasc Interv Radiol; 2004 Oct; 15(10):1129-31. PubMed ID: 15466800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institution's experience.
    Ivy JJ; Geller M; Pierson SM; Jonson AL; Argenta PA
    Gynecol Oncol; 2009 Sep; 114(3):420-3. PubMed ID: 19560189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of symptomatic ascites and post-operative lymphocysts with an easy-to-use, patient-controlled, vascular catheter.
    Stukan M; Leśniewski-Kmak K; Wróblewska M; Dudziak M
    Gynecol Oncol; 2015 Mar; 136(3):466-71. PubMed ID: 25434633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Permanent tunneled drainage for malignant ascites: initial experience with the PleurX® catheter].
    Saiz-Mendiguren R; Gómez-Ayechu M; Noguera JJ; García-Lallana A; Marginet C; Cano D; Benito A
    Radiologia; 2010; 52(6):541-5. PubMed ID: 20863540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal catheter site metastasis in a patient with advanced ovarian cancer.
    Ramirez I; Bansal N; Hoffman M
    Am J Hosp Palliat Care; 2012 May; 29(3):241-2. PubMed ID: 21606122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.